𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Circulating neuroendocrine markers in patients with prostate carcinoma

✍ Scribed by Alfredo Berruti; Luigi Dogliotti; Alessandra Mosca; Maurizio Bellina; Mauro Mari; Mirella Torta; Roberto Tarabuzzi; Enrico Bollito; Dario Fontana; Alberto Angeli

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
112 KB
Volume
88
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neuroendocrine differentiation in prosta
Neuroendocrine differentiation in prostatic carcinoma
✍ Abrahamsson, Per-Anders πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 185 KB πŸ‘ 2 views

## BACKGROUND. Information is presented on prostatic neuroendocrine cells and neuroendocrine differentiation in prostatic carcinoma. The prognostic and therapeutic implications of neuroendocrine differentiation in prostatic carcinoma are reviewed. METHODS. Data are presented that support the intri

Neuroendocrine differentiation in carcin
Neuroendocrine differentiation in carcinomas of the prostate: Do neuroendocrine serum markers reflect immunohistochemical findings?
✍ Angelsen, Anders; Syversen, Unni; Haugen, Olav A.; Stridsberg, Mats; MjΓΈlnerΓΈd, πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 307 KB πŸ‘ 1 views

The aim of the present study was to examine the correlation between the immunohistochemical findings and the serum markers for neuroendocrine (NE) cells in patients with carcinoma of the prostate. Preoperative serum values of chromogranin A (CgA), chromogranin B (CgB), pancreastatin (Pst), neuron-sp

Neuroendocrine differentiation in prosta
Neuroendocrine differentiation in prostatic carcinoma: An update
✍ di Sant'Agnese, P. Anthony πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 2 views

## BACKGROUND. Neuroendocrine differentiation in prostatic carcinoma may be related to the growth and prognosis of prostate cancer, especially androgen-insensitive tumors. MATERIALS AND METHODS. This update reviews new investigations relating to neuroendocrine differentiation of prostatic carcinom

Use of neuroendocrine serum markers in t
Use of neuroendocrine serum markers in the follow-up of patients with cancer of the prostate
✍ Angelsen, Anders; Syversen, Unni; Stridsberg, Mats; Haugen, Olav A.; MjΓΈlnerΓΈd, πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 274 KB πŸ‘ 1 views

Neuroendocrine (NE) differentiation of prostatic adenocarcinomas has received increasing attention in recent years as a result of possible implications on prognosis and therapy. The incidence of NE cells in tumors has been reported from 10% up to 100%. Several studies have shown chromogranin A (CgA)